3-Azetidinecarboxylic acid, 1-(3-bromo-2-pyridinyl)-, 100mg

5,5,5-Trifluoro-4-oxopentanoic acid, 97%, 500mg

(S)-2-(benzyl(methyl)amino)-4-fluoro-4-methylpentanoic acid, 97%, 100mg

6-Chloropyridine-2,3-dicarboxylic acid, 97%, 5g

2-[(3,4-dichlorobenzyl)thio]-4,5-dihydro-1H-imidazole hydrobromide, 95.0%, 500mg

Thiophene-3,4-diamine dihydrochloride, 95.0%, 1g

D(+)-Galactose, min. 98%, for biochemistry, 100 g, plastic packaging.

METHYL 4-ETHYL-3-ETHYNYLBENZOATE, 95.0%, 250mg

N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)phenyl)acetamide, 95.0%, 1g

4,4'-Dinitrodiphenyl Ether>99.0%(GC)10g

(2E)-1-(3-bromophenyl)-3-(3-chlorophenyl)prop-2-en-1-one, 95.0%, 2g

N-CYCLOPENTYL-2-NITROANILINE, 95.0%, 100mg

2-[(2-oxo-2-phenylethyl)thio]nicotinic acid, 95.0%, 1g